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In the current work, two groups of chlorhexidine mucoadhesive buccal tablets were prepared, using
either rod or irregularly-shaped spherical particles of hydroxypropyl methylcellulose and different ratios
of poloxamer 407 (P407). The tablets were designed to release the drug over two hours. Their physico-
chemical properties and drug release profiles were investigated. The impact on dry granulation, the ex-
vivo mucoadhesion, the swelling index, the morphology of swollen tablets and the drug release kinetic
were investigated. Drug-polymers chemical interaction was studied using Fourier Transforms Infrared
Spectroscopy (FTIR) and differential scanning calorimetry (DSC). Due to different particle shapes, the
preparation of dry granules required a 40 KN force for rod-shaped particles compared to 10 KN for the
irregularly-shaped spherical particles. All formulations showed at least two-hours residence time using
ex-vivomucoadhesion. Statistically, there was no significant difference in the swelling index, drug release
nor its kinetic for both groups. However, the microscopical morphology of the swollen tablet and the size
of the pores were affected by particle shape. Increasing the ratio of P407 to 62.5% resulted in a pro-
nounced increase in drug release from around 60% to >90% after two hours. Following the FTIR and
DSC analyses, no chemical interaction was noted apart from the steric hindrance effect of P407, which
was observed even with the physical mixtures.
 2019 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hydroxypropyl methylcellulose (HM) has widely been used in
the preparation of hydrophilic controlled release matrices due to
its water solubility, pH stability and resistance to enzymatic degra-
dation, ease of manufacturing and low cost. It gels and swells upon
contact with water forming a gelatinous layer that controls drug
release (Ghori and Conway, 2015; Maderuelo et al., 2011). Due to
its mucoadhesive and hydrogel-forming properties, it has beeninvestigated in buccal drug delivery and is included in marketed
products (Sudhakar et al., 2006). There are several factors which
affect drug release from HM matrices, for instance, particle size
(Wan et al., 2001), force of compression (Velasco et al., 1999),
molecular weight (Gao et al., 1996), viscosity (Campos-Aldrete,
1997), drug polymer ratio (Velasco et al., 1999), and the incorpora-
tion of other polymers or excipients (Xie et al., 2017). There have
been only a limited number of investigations which have high-
lighted the effect of particle shape on tablet swelling and drug
release. For instance, Gustafsson et al. (1999) assumed that fibrous
or rod-shaped HM particles have a lower hydration rate compared
to irregular particles, which results in a lower gelling rate and con-
sequently decreases the rate of drug release. Moreover, the mor-
phology of the powder affects its flow properties and
compactability. Rod-shaped interlocked upon compaction and pro-
duced higher tensile strength tablets, which consequently resulted
in a decreased drug release rate (Gustafsson et al., 2003). Li et al.
(2005) found that the rod-shaped particles in Methocel powderexidine
2 E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxxalso interlocked, producing a stronger matrix which affected tablet
swelling and decreased the rate of drug release.
Poloxamer 407 (P407) or Pluronic F127 is a non-ionic surfactant
polymer and has a thermo-reversible hydrogel-forming ability
with a mucoadhesive property. It gels at a concentration of >20%
at 25 C (Ruel-Gariépy and Leroux, 2004). It is a copolymer of poly-
ethylene oxide and polypropylene oxide, with the hydrophilic nat-
ure of the former and the hydrophobic nature of the latter resulting
in an amphiphilic molecule with consequent surfactant properties
(Kabanov et al., 2002). It has a wide application in drug delivery, for
example, in parenteral, ophthalmic, inhaler, oral solution, suspen-
sion, and topical formulations (Dumortier et al., 2006). In the cur-
rent work, P407 was chosen due to its pronounced gelling
properties and high viscosity of 3100 cP which is attributed to its
high molecular weight compared to other poloxamers and its
availability as microprills (Matanovi et al., 2014). Although, it is
not commonly used in controlling the release of the drug from
solid dosage forms, in the current work it was formulated in tablet
dosage form to control the release of chlorhexidine (CHD) together
with HM by exploiting its thermo-reversible hydrogel-forming
properties which promotes tablet wetting as a result of its surfac-
tant property.
CHD is cationic at physiologic pH, its bactericidal and fungicidal
activity results from its ability to bind to phosphate-containing
proteins in the bacterial or fungal cell walls and membranes which
leads to structural disruptions and leakage of cytoplasmic compo-
nents (Lim and Kam, 2008). The main advantage of oral formula-
tions of CHD is their lack of a specific cellular target for
microbiocidal activity which results in the retardation of the devel-
opment of resistance against CHD (Ankola et al., 2008). CHD
mouthwashes are prescribed as adjuvant for the treatment of
oropharyngeal candidiasis (OPC) (Pereiro Ferreirós et al., 2012).
The greatest disadvantage of current CHD formulations is their
short retention and activity time in the oral cavity. Consequently,
there is a real need for a new approach to the localised, prolonged
delivery of antifungal agents for enhanced OPC therapy. The advan-
tages of this mode of drug delivery are that it reduces the systemic
side effects of the drug, minimizes the dose of the drug required
and provides targeted drug delivery (Sankar et al., 2011).
In the present study, the impact of HM particle shape and/or the
ratio of P407 on the properties and the release of CHD from
mucoadhesive matrices are investigated. To the best of our knowl-
edge, there has been no previous investigation into the impact of
the shape of HM particles on tablet behaviour and release profile,
after being dry granulated. The effects on the physicochemical
properties of CHD matrix tablets for local oral drug delivery of
HM rod and irregularly-shaped spherical particles were studied.
The tablets were designed to control the release for two hours
which might not be achieved by HM. Accordingly, P407 was added
to increase the hydrophilicity and maintain the hydrogel network
structure. The effect of P407 on tablet behaviour and the CHD
release profile was investigated.
2. Materials and method
2.1. Materials
MethocelTM F4M premium hydroxypropyl methylcellulose
(Methocel, viscosity of 2663–4970 cps for 2% solution at 20 C,
27–30% methoxyl and 4–7.5% hydroxypropyl substitution) was
kindly donated by the Dow-Colorcon Company in the U.K. Hydrox-
ypropyl methylcellulose (HPMC, Mn  86,000, viscosity of 4000
cps for 2% solution at 20 C, 29% methoxyl and 7% hydroxypropyl
substitution), poloxamer 407 (P407) and chlorhexidine diacetate
salt hydrate (CHD) were purchased from Sigma Aldrich in the UK
and Magnesium stearate from Alfa Aesar, also in the UK.Please cite this article as: E. Al-Ani, C. Martin, S. T. Britland et al., The effect of th
from mucoadhesive buccal tablets, Saudi Pharmaceutical Journal, https://doi.o2.2. Solubility of CHD
The solubility of CHDwas investigated in ultra-pure water and a
phosphate buffer saline (PBS) solution pH 6.8, as a simulated sali-
vary pH to select the most appropriate dissolution medium with a
sink condition.
The solubility of CHD was determined by adding excess CHD to
3 mL of water or a PBS solution at pH 6.8. The samples were shaken
at 37 ± 0.1 C for 24 h. The suspensions were filtered through a
0.45 mm Millipore membrane filter and the concentration of CHD
was measured by UV detection at k254 nm (Biochrom WPA Bio-
wave II UV-Spectrophotometry, UK).
2.3. Particle size and morphological analyses
The raw materials were assessed for their size. The volume-
weighted particle size of Methocel, HPMC, P407 and CHD was
assessed by laser diffraction using a Malvern Mastersizer 3000
with an Aero S dry dispersion unit system (Malvern Instruments,
Malvern, UK). The cumulative particle sizes at 10, 50 and 90% were
displayed as D0.1, D0.5 and D0.9, respectively.
The morphology of the granules and the raw materials was
assessed by scanning using electron microscopy (SEM), (Zeiss
Evo 50EP SEM, Germany).
2.4. Preparation of tablets using the dry granulation technique
The formulations of CHD mucoadhesive tablets were prepared
as shown in Table 1. The powders were blended for 5 min in a V-
shaped powder blender (CapsulCN, China). Then, dry granules
were prepared following the slugging method (Tuǧcu-Demiröz
et al., 2004) using a manual hydraulic hand press (diameter = 4 cm,
weight = 5.5 ± 0.5 g). Slugs prepared using HPMC and Methocel
were formed with a compression force of 10 and 40 KN, respec-
tively. The slugs were crushed into granules and passed through
a 1 mm screen (mesh no. 18). Magnesium stearate (0.5%) was
added and mixed for 3 min prior to the compression of the gran-
ules into tablets.
The tablets were pressed using a heavy duty mini rotary tablet
machine (STC ZPS Shanghai, China) with a biconvex 6 mm diame-
ter round shape punch. The average central thickness was 1.5 mm
and the wall thickness (edge) was 1.0 mm.
2.5. Flow properties and compressibility index
The bulk and the tapped volume of the powder blends and the
granules were assessed using a tapped Density tester (Varian, UK).
The tapped volumes were obtained by subjecting the powders to
200 taps each time until a constant volume was achieved. Carr’s
Compressibility index (CI) was calculated using the flowing
equation
Carr
0
s Index ¼ 1 Vt=V0ð Þ
where V0 is bulk volume and Vt is the tapped volume.
2.6. Characterisation of the buccal tablets
2.6.1. Friability and tensile strength
A sample of approximately 1 g of each formulation was evalu-
ated for their friability using a friability tester (Charles Ischi AG,
AE-1, UK), and rotated 100 times at 25 rpm. The mechanical
strength of the biconvex tablet was calculated using the following
equation (Pitt et al., 1988).
rx ¼ 10F=pD2 2:84H=D 0:126H=W þ 3:15W=Dþ 0:01½ 1e source and the concentration of polymers on the release of chlorhexidine
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Table 1
Formulations of CHD mucoadhesive buccal tablets.
Formulations Weight (mg)/tablet
CHD HPMC Methocel P407 Tablet weight
F1 5 25.0 – – 30
F2 20.5 – 4.5
F3 17.5 – 7.5
F4 11.5 – 13.5
F5 6.25 – 18.75
F6 – 25.0 –
F7 – 20.5 4.5
F8 – 17.5 7.5
F9 – 11.5 13.5
F10 – 6.25 18.75
E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxx 3where rx is the tensile strength, F is tablet hardness (Newtons), D is
tablet diameter, H is tablet thickness, and W is central cylinder
thickness (tablet wall height), with all tablet dimensions in mm.
Tablet hardness was measured using a Varian VK 200, (UK)
hardness tester (n = 10).
2.6.2. Ex-vivo mucoadhesion analysis
The mucoadhesion was determined as a function of dosage
form residence time using a modified protocol adopted from
Nafee et al. (2003). Freshly harvested chicken crops were carefully
washed to remove any residue of food the chicken had consumed,
and they were subsequently stored at 80 C. The crops were
defrosted before use, cut into small pieces (1 cm  2 cm) and fixed
to a glass slide using cyanoacrylate glue. The crop was hydrated
using one drop of ultrapure water before a CHD tablet was placed
on top and weighed down with a 4 g weight for 20 s to aid the
adhesion process. The glass slide was then placed into the disinte-
gration apparatus tubes (cylinders) (Varian VK 100, UK), prefilled
with 37 ± 0.2 C of ultrapure water (Fig. 1). A test, similar to the
disintegration test, was performed at 50 rpm for 120 min with
periodic sample examination for every 15 min to evaluate if the
tablets had become detached from the chicken crops. The formula-
tion of each tablet was performed in triplicate.
2.6.3. Swelling index
The swelling index was determined by weighing an individual
CHD tablet (W0) and sticking it to a previously weighed glass cov-
erslip using a single water droplet and allowing it to equilibrate for
30 s. The coverslip was then placed vertically in a beaker in a
37 ± 0.2 C water bath (Clifton, Nickel-Electro Ltd, UK). The weight
of the swollen tablet (Ws) was recorded at 30, 60, 90 and 120 min.
The swelling index (SI) was calculated using the following equation
(Kassem et al., 2014).
SI ¼ ðWs W0Þ=W0Fig. 1. Ex-vivo mucoadhesion using the disintegration apparatus.
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The morphology of aqueous media swollen tablets was investi-
gated. They were prepared by adding 0.5 mL distilled water to each
tablet in a 5 mL test tube and left until swollen. They were then
freeze-dried using a Beta 1–8 LSC Freeze Dryer (Christ, UK). The
tablets were cut in half and analysed using SEM as previously
described. The surface area of the pores was measured using Ima-
geJ 1.51n software.
2.6.4.1. Comparison of dissolution rate. Similarity and difference fac-
tors were applied to compare the dissolution profiles of both
groups of formulations. The similarity factor (f2) was calculated
using the equation below. The results fell between 0 and 100%,
and an f2 of 50 suggests a similarity between the standard and
the test (Costa and Lobo, 2001).
f 2 ¼ 50 log 1þ 1=nð Þ
Xn
t¼1ðRt  TtÞ
2
h i0:5
 100
 
where n is the number of time points, Rt is the percent release of the
standard and Tt is the percent release of the test.
The difference factor (f1) was calculated using the equation
below. Values of between 0 and 15 indicate that the difference
between the samples is acceptable. When f1 = 0, the two samples
are considered identical (Costa and Lobo, 2001).
f 1 ¼
Xn
t¼1jRt  Tt
h i
=
Xn
t¼1ðRt þ TtÞ=2
h in o
 1002.6.5. In-vitro dissolution of CHD (Apparatus I)
The dissolution was performed using Varian 705 DS BP Dissolu-
tion Apparatus type I (basket method) (Varian, UK). One tablet of
each formulation was placed in 500 mL of ultrapure distilled water
at 37 ± 0.1 C, with the basket rotating at 50 ± 1 rpm. At predeter-
mined time intervals, 4 mL was withdrawn from the dissolution
medium and replaced with the same volume of fresh media. The
CHD concentration was determined spectrophotometrically at
k254 (Biochrom WPA Biowave II UV-Spectrophotometry, UK).
2.6.5.1. Kinetics of drug release. The kinetics of CHD release were
investigated to further understand the mechanism of CHD release
and the effect of the different ratios of the polymers. Five models
(Costa and Lobo, 2001) were used to analyse the release of CHD
from the tablet matrices (Table 2).
2.7. Fourier transform Infrared Spectroscopy (FTIR) and differential
scanning calorimetry (DSC)
FTIR was used to investigate the possibility of interaction
between the polymers and CHD. Spectra were obtained using a
Bruker Alpha spectrometer (Germany) scanning and ranged from
4000 to 400 cm1.e source and the concentration of polymers on the release of chlorhexidine
rg/10.1016/j.jsps.2019.04.012
Table 2
Kinetic drug release models.
Model Equation
Zero order Q ¼ Q0K0t
First order logQ ¼ LogQ0K1t=2:303
Higuchi Qt ¼ KHt1=2
Hixon-Crowell Q1=3 ¼ Q1=30  Kct
Korsmeyer-Peppas Qt=Q1 ¼ Ktn
Where Q is the amount of drug released or dissolved
at time t; Q0 is the amount of drug release or dissolved
at time t (usually t = 0); Qt/Q1 is the fraction of drug
released at time t; K is constant, and n indicates the
release mechanism.
4 E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxxDSC analysis was performed to investigate the interaction
between CHD and the polymers during the processing steps. Sam-
ples of 5.0 ± 0.2 mg each of CHD, HPMC, P407, F10 Physical mix,
F10 granules and F10 tablet were investigated. Each was heated
in an aluminium pan under a nitrogen flow of 40 mL/min from
25 C to 300 C at a scan rate of 10 C/min. The analysis was per-
formed using Mettler Toledo DSC823e (Switzerland).3. Results and discussion
3.1. Solubility of CHD
The solubility of CHD was investigated to determine the most
appropriate dissolution medium to achieve sink condition. Its sol-
ubility in water and phosphate buffer saline (PBS) at pH 6.8 was
23.069 ± 1.928 and 0.047 ± 0.0124 mg/mL, respectively. The vol-
ume of the dissolution media should be at least 3–10 times that
of the saturated volume (Rohrs, 2001). Simulated pH saliva using
PBS did not achieve sink condition, which is an important criterion
in dissolution. Water showed more than 10 times the saturated
volume and was therefore selected as the dissolution medium.3.2. Particle size and morphology
The particle sizes of CHD and their distribution and excipients
are shown in Fig. 2 and Table 3. Both Methocel and HPMC have lar-
ger particles than CHD and P407, which is confirmed by the SEM
micrographs (Fig. 3).
The SEM micrographs (Fig. 3) correspond with the laser diffrac-
tion results. Both CHD and P407 have smaller particle sizes and the
latter tend to be more spherical. However, HPMC and Methocel
possess larger particle sizes with irregular spherical and rod
shapes, respectively.0
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Fig. 2. Particle size distribution of CHD, Methocel F4M, HPMC and P407.
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distribution peak and a higher span value compared to HPMC
(Fig. 2) which can be attributed to the rod-like shape of the parti-
cles seen under SEM (Fig. 3) (Naito et al., 1998). The particle size
distribution of HPMC approximates to a nearly normal distribution
pattern with SEM revealing more spherical or irregular spheres.
3.3. Effect of particle morphology on tablet preparation
The morphology of both the HPMC and Methocel samples
(Fig. 3) strongly influenced their flow behaviour’ HPMC displays a
‘‘passable” powder flow (CI of 21.67), whereas Methocel has ‘‘poor”
flow (CI of 33.33) (British Pharmacopoeia Comission, 2017). This
finding was not unexpected as Hassan and Lau (2009) had reported
the impeded flow of needle-shaped calcium carbonate particles (CI
of 40) which resulted from inter-particulate interactions and
aggregation. Moreover, the span value of Methocel is higher than
HPMC which resulted in a decrease in the flowability. This con-
firms a previous finding by Liu et al. (2008), who found that the
flowability is affected by both particle size and distribution. A par-
ticle size of below 100 mm resulted in increased cohesiveness and
decreased flowability (Table 3) (Liu et al., 2008), whereas a nar-
rower distribution indicated better flowability. The various powder
formulation blends were found not to be flowable (Table 4) and
this may be due to the smaller mean particle size population of
the formulations, resulting in a relatively high surface area and
the potential for increased inter-particulate interactions which
can decrease flowability. Dry granulation improved the flow prop-
erties of all formulation blends with most improving from ‘very,
very poor’ to ‘very poor’, or from ‘very poor’ to ‘poor’ based on
the British Pharmacopoeia.
The applied force used to prepare the HPMC granules was 10
KN. In contrast, Methocel granules were initially prepared at 10
and 40 KN, but the 10 KN samples were rejected due to no
improvement in flowability. This may be attributed to the rod-
like shape of Methocel particulates, which results in weak granules
compact which is unable to maintain its shape. The flowability of
granulated formulations of HPMC and Methocel prepared by both
forces (10 or 40 KN) was similar. Increasing the P407 content
decreased the flowability of the powder blends, most likely
because of the irregular shape, small particle size and cohesive
properties of P407, which increases inter-particulate interactions
and decreases packing efficiency as evidenced by a relatively high
CI of 40 (Garg et al., 2018). Again, flow properties were improved
after granulation, possibly as a result of the low melting point
and the waxy nature of the P407, which may have decreased
inter-particulate interactions and improved the packing efficiency.
Granulated formulations with a high P407 ratio had a CI of 27. The
SEM images confirmed that there was no great improvement in the
flowability of granules (Fig. 4) due to the generation of fine parti-
cles when using dry granulation (Herting and Kleinebudde, 2007).
3.4. Tensile strength and friability
All the tablets showed a tensile strength of less than 1 MP, with
Methocel formulations showing relatively higher tensile strengths
than HPMC formulations. This might be due to the higher force
used in the granulation for the former. All had acceptable levels
of friability of less than 1% (Table 5).
3.5. Ex-vivo mucoadhesion
Tablets were prepared with a convex surface. The advantage of
this type of surface is that it prevents the tablet from dislodging
due to movement of the mouth and reduces contact with the ton-
gue and the teeth (Maurya et al., 2010). It makes the tablet lesse source and the concentration of polymers on the release of chlorhexidine
rg/10.1016/j.jsps.2019.04.012
Table 3
Particle size distribution of CHD, Methocel F4M, HPMC and P407.
Raw material D 0.1 (mm) D 0.5 (mm) D 0.9 (mm) Span (mm)
CHD 5.14 21.00 69.00 3.04
HPMC 33.00 84.60 172.00 1.64
Methocel 26.50 70.80 202.00 2.48
P 407 11.50 34.50 74.30 1.82
Fig. 3. SEM images of (a) CHD (b) P407, (c) HPMC and (d) Methocel x500.
Table 4
Compressibility index (CI%) for tablet blends before and after granulation.
Formulations Powder blends Granules
CI% Flow character CI% Flow character
F1 36.59 ± 4.00 Very poor 29.41 ± 1.03 Poor
F2 42.31 ± 1.61 Very, very poor 32.38 ± 1.58 Very poor
F3 42.86 ± 1.55 Very, very poor 32.29 ± 1.47 Very poor
F4 31.43 ± 2.91 Very poor 26.38 ± 0.00 Poor
F5 34.21 ± 3.62 Very poor 27.92 ± 0.92 Poor
F6 43.74 ± 1.32 Very, very poor 34.92 ± 1.37 Very poor
F7 39.28 ± 2.24 Very, very poor 34.85 ± 0.00 Very poor
F8 41.36 ± 2.12 Very, very poor 30.33 ± 3.21 Poor
F9 38.45 ± 4.43 Very, very poor 27.50 ± 0.87 Poor
F10 42.36 ± 5.81 Very, very poor 26.83 ± 0.76 Poor
E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxx 5brittle during manufacturing and handling. Furthermore, upon
application, it promotes rapid hydration around the perimeter
and facilitates adhesion (Foreman et al., 2006).
All tablets successfully adhered to the chicken crop when
repeatedly immersed, using the disintegration tester, in the aque-
ous medium for two hours, which corresponds to the selected res-
idence time for CHD release from the tablets in the buccal cavity.
This successful mucoadhesion may be due to the chain entangle-
ment and physical interlinking interaction of both the Hydrox-
ypropyl methylcellulose polymers and the P407 with the chicken
crop mucous membrane. Neither polymer is capable of interactingPlease cite this article as: E. Al-Ani, C. Martin, S. T. Britland et al., The effect of th
from mucoadhesive buccal tablets, Saudi Pharmaceutical Journal, https://doi.owith the mucin component of mucous as they are both uncharged
(Sosnik et al., 2014).3.6. Swelling index (SI) and tablet morphology
The swelling index for both Methocel and HPMC formulations
(Fig. 5, supplemental data) increased with time. Statistical analysis
(two-way ANOVA with replication) revealed no statistical signifi-
cance (p > 0.05) between HMPC and Methocel formulations (F1
and F6). This indicates that the morphology of HPMC and Methocel
particles does not have any impact on the swelling index. However,e source and the concentration of polymers on the release of chlorhexidine
rg/10.1016/j.jsps.2019.04.012
F3
F1 F6
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F10F5
F4
Fig. 4. SEM images of selected granules of HPMC and Methocel formulations, x200.
6 E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxxthere was a significant difference for each group of formulations
(p < 0.001) for HPMC (F1 and F5) and Methocel (F6–F10).
Increasing P407 led to a significant decrease in the swelling
index (p < 0.001), for both HPMC formulations. Upon hydration,
the mobility of the macromolecules in Methocel and HPMC
increases along with the rate of water movement (Siepmann and
Peppas, 2012). Moreover, hydrated P407 arranges itself into micel-
lar structures that subsequently adopt a cubic shape once the
hydrogel is formed. Intriguingly, the presence of HPMC in some
of these formulations might facilitate the formation of a network
of interconnected P407 micelles (Koffi et al., 2006).Please cite this article as: E. Al-Ani, C. Martin, S. T. Britland et al., The effect of th
from mucoadhesive buccal tablets, Saudi Pharmaceutical Journal, https://doi.oSEM micrographs of swollen tablets (Fig. 6) show a sponge-like,
porous network with a strong relationship between the shape of
the pores and the morphology of the particles in Methocel and
HPMC polymers (Fig. 3) and their ratios in the formulations. F1
and F2 show smaller and more spherical pores compared to F6,
F7 and F8 which have elongated, larger pores. The effect is promi-
nent when the ratio is greater than 50% in the tablet. For instance,
the average cross-sectional surface area of the pores in F1 and F6
was 0.46 ± 0.86 and 1.86 ± 2.95 mm2, respectively. Although the
average size of pores in F5 is 4 times that of F1, the total surface
area of the pores was 0.203 mm2 for the former and 0.234 mm2 fore source and the concentration of polymers on the release of chlorhexidine
rg/10.1016/j.jsps.2019.04.012
Table 5
Tensile strength (n = 10) and friability (1 g) of CHD tablets.
Formulations Tensile strength (MPa) Friability (%)
F1 0.57 ± 0.19 0.48
F2 0.49 ± 0.19 0.28
F3 0.51 ± 0.14 0.12
F4 0.73 ± 0.21 0.09
F5 0.62 ± 0.15 0.36
F6 0.78 ± 0.14 0.04
F7 0.78 ± 0.18 0.02
F8 0.66 ± 0.21 0.01
F9 0.74 ± 0.28 0.06
F10 0.88 ± 0.20 0.25
E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxx 7the latter, with a ratio of 0.9. This indicates that although the size
and the morphology of the pores are different, the total surface
area is not greatly affected by the morphology of the polymeric
particles. Increasing P407 leads to the formation of irregular pores,
possibly because of its surfactant properties which increase the
solubility of other polymers and distorts their shapes. Another pos-
sibility is that it might be affected by the thermosensitive proper-
ties of P407, which melts at a low temperature, meaning that pore
damage may occur during the freeze-drying process or during the
sample cutting of freeze-dried tablets.3.7. In-vitro dissolution of CHD and data analysis
The cumulative CHD release from both groups of tablets was
affected by the ratio of P407. Increasing P407 content elevates drug
release by as much as 30% for HPMC formulations (F1 to F5). For
example, 60.53% of CHD was released from F1 compared to
94.27% of CHD which was released from F5. Moreover, the cumu-
lative CHD release from Methocel formulations F6 and F10 with
the same composition as F1 and F5 were 57.77% and 94.58%,
respectively. The increase in drug release was attributed to the sol-
ubilising activity of P407 (Fig. 7). The copolymer P407 is a surfac-
tant which is widely used to improve the aqueous solubility of
poorly soluble drugs (Dumortier et al., 2006), and can also form a
hydrogel at body temperature. However, the morphology of the
particles of Methocel and HPMC did not affect CHD release, which
might be explained by the equivalent cross-sectional surface area
of pores in F1 and F6. Moreover, both formulations are similar in
terms of cumulative drug release based on similarity factor (f2)
and difference factor (f1), with values of 81.1% and 6.87, respec-
tively. F1 and F6 showed a cumulative release after two hours of
60.7% and 57.7%, while F5 and F10 showed 93.0% and 94.6%,0
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Fig. 5. swelling index of CHD tablets (a) HPMC formulations and (b) Methocel formu
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Although different compression forces of 10 KN for HPMC for-
mulations and 40 KN for Methocel formulations were used to pre-
pare the granules, this should not affect drug release. Velasco et al.
(1999) reported that compression force has a minimal effect on
drug release or the kinetics of release but can influence initial
matrix porosity (before hydration).
The kinetics of CHD release was investigated by fitting the
release data to the following models: zero order, first order, Higu-
chi, Hixson-Crowell and Korsmeyer-Peppas models (Table 2).
Using the correlation coefficient (R2) values, the tablets fitted most
closely with the Korsmeyer-Peppas kinetic model and the expo-
nent n was found to be 0.45 < n < 0.89 (Table 6). This indicates that
drug release is anomalous from cylindrical tablet (0.45 represent-
ing diffusional control and 0.89 indicating case-II transport which
corresponds to zero order kinetic). Thus, CHD release is anomalous
(Siepmann and Peppas, 2012). This leads to the conclusion that
neither the morphology of polymer particles nor the ratio of
P407 had an effect on the mechanism of drug release.3.8. Drug polymer interaction (FTIR and DSC)
The FTIR spectra revealed that HPMC and Methocel are identical
in terms of chemical composition. Moreover, analyses were per-
formed (Fig. 8) to evaluate possible interactions during the granu-
lation and tableting process which might have resulted from the
low melting point of P407. CHD displayed peaks at 3325 and
3119 cm1 (asymmetric and symmetric NH stretching vibrations),
2938 and 2886 cm1 (asymmetric and symmetric CH stretching),
1624 cm1 (CN stretching vibration of imine group),
1522,1483 cm1 (NH bending vibration of secondary amine and
imine groups), 1406 cm1 (C@C stretching vibrations of aromatic
rings), 1290 and 1245 cm1 CN stretching, 819 cm1 (out of plane
vibration of the aromatic ring and the CCl) group’s spectra at
718 cm1 (Holešová et al., 2014, and Yang et al., 2007). The charac-
teristic peaks of HPMC are at 3445 cm1 (OH stretching) and
2897 cm1 (CH stretching), 1375 cm1 (asymmetric CH3 bending
vibration), 1049 cm1 (CAO asymmetric stretching vibration) and
942 cm1 (CAO symmetric stretching vibration (Ding et al.,
2015). P407 is characterised by principal peaks at 2875 cm1 (CH
stretching), 1346 cm1 (OH bending) and 1094 cm1 (CO stretch-
ing) (Vyas et al., 2009). The analyses of tablet formulations (Fig. 8
a and c) reveal that increasing the concentration of P407 leads to
a decreased intensity of CHD and the disappearance of hydrogen
bonding peaks at 3325 and 3119 cm1. This is prominent in F5
and F10. In contrast, F1, F2, F6 and F7 show a combination of the0
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Fig. 6. SEM micrographs of cross-section of freeze-dried swollen tablets.
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between CHD and P407 is attributed to the steric hindrance prop-
erties of P407, resulting in the shielding of CHD (Göppert andPlease cite this article as: E. Al-Ani, C. Martin, S. T. Britland et al., The effect of th
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the CO stretching of HPMC, Methocel and P407 combining into one
peak at around 1097 cm1 in F2, F8 and F5 and F8-F10. However, ine source and the concentration of polymers on the release of chlorhexidine
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Fig. 7. Cumulative percentage release of CHD from (a) HPMC formulations and (b) Methocel formulations in ultrapure water at 37 ± 0.1 C and 50 rpm, n = 3 ± SD.
Table 6
CHD release kinetics using different models.
Zero Order (R2) First order (R2) Higuchi (R2) Hixon crowel (R2) K-Peppas (R2) K-Peppas (n)
F1 0.9702 ± 0.0227 0.9826 ± 0.0149 0.9723 ± 0.0262 0.9697 ± 0.0285 0.9979 ± 0.0010 0.717 ± 0.139
F2 0.9795 ± 0.0143 0.9825 ± 0.0078 0.9655 ± 0.0244 0.9757 ± 0.0188 0.9967 ± 0.0023 0.747 ± 0.137
F3 0.9329 ± 0.0378 0.8943 ± 0.0843 0.9818 ± 0.0063 0.8567 ± 0.1076 0.9872 ± 0.0029 0.541 ± 0.105
F4 0.9776 ± 0.0028 0.9867 ± 0.0078 0.9773 ± 0.0031 0.9777 ± 0.0130 0.9985 ± 0.0008 0.686 ± 0.027
F5 0.9850 ± 0.0048 0.9806 ± 0.0035 0.9648 ± 0.0050 0.9940 ± 0.0014 0.9984 ± 0.0012 0.764 ± 0.029
F6 0.9712 ± 0.0054 0.9833 ± 0.0067 0.9736 ± 0.0063 0.9483 ± 0.0128 0.9965 ± 0.0007 0.698 ± 0.033
F7 0.9663 ± 0.0025 0.9854 ± 0.0028 0.9796 ± 0.0019 0.9714 ± 0.0042 0.9959 ± 0.0005 0.671 ± 0.018
F8 09791 ± 0.0107 0.9972 ± 0.0010 0.9606 ± 0.0071 0.9942 ± 0.0030 0.9983 ± 0.0015 0.796 ± 0.009
F9 0.9727 ± 0.0117 0.9952 ± 0.0012 0.9703 ± 0.0105 0.9894 ± 0.0081 0.9981 ± 0.0015 0.740 ± 0.044
F10 0.9907 ± 0.0079 0.9700 ± 0.0143 0.9475 ± 0.0190 0.9872 ± 0.0059 0.9987 ± 0.0005 0.870 ± 0.113
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Fig. 8. FTIR spectra of (a) HPMC formulations, (b) F5 physical mix (PM), granules (Gran) and tablet (Tab), (c) Methocel formulations and (d) F10 PM, Gran and Tab.
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10 E. Al-Ani et al. / Saudi Pharmaceutical Journal xxx (xxxx) xxxF1 and F6, this peak shifts to 1049 cm1. Further investigation was
performed to analyse F5 and F10, the physical mix, the granules
and the tablets (Fig. 8 b and d). All FTIR spectra have identical
peaks, meaning that during the mixing process of the excipient,
hydrophobic interactions occur between CHD and P407 ending in
steric hindrance by the latter. Although this interaction is more
common in liquid formulations, in the current formulation the
interaction is aggravated by the small particle size of both CHD
and P407.
Fig. 9 shows the DSC thermograms for raw materials, the phys-
ical mixture, the granules and the tablet of F10 formulation, which
has the highest drug release. CHD has two melting peaks at 158
and 176 C, which indicates its polymorphic nature. Methocel
reflects its amorphous nature while P407 has a melting peak at
57 C. The F10 physical mix, the granules and the tablet thermo-
grams showed that the endothermic peak of poloxamer occurred
at around the same temperature. The first melting peak of CHD
was shifted to 156 C in the physical mix and to 153 C in the gran-
ules and the compressed tablet. The small melting peak disap-
peared in the physical mix and granules but in the tablet, it
shifted to 173 C. The shifting and the disappearance of the melting
peaks in the physical mix and the granules indicate there is an
interaction between the chlorhexidine and the P407. However,
the re-appearance of the second endothermic peak in the tablet
is attributed to phase separation resulting from tablet compression
(Singh et al., 2016).
The interaction between the excipients and CHD were tested
using FTIR and DSC. The FTIR spectra revealed that increases in
the ratio of P407 led to a decrease in the intensity of CHD which
can be attributed to steric hindrance by P407. The FTIR spectra0 50 100 150 200
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Fig. 9. DSC thermograms of F10 physical mix (PM), Granules (GRAN), tablet (TAB),
CHD, Methocel and P407.
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from mucoadhesive buccal tablets, Saudi Pharmaceutical Journal, https://doi.ofor the F5 physical mix, the granules and the tablet showed identi-
cal spectra with that of the F10. This indicates that no interaction
occurred during the process of tableting and the sources of the
polymer showed no differences in behaviour. Moreover, DSC anal-
ysis was performed on the F10 formulation only and showed no
interactions between the drug and the polymers in the prepared
table.
4. Conclusions
CHD buccal tablets were successfully prepared using two differ-
ent sources of hydroxypropyl methylcellulose polymer. Both
groups of formulations showed comparable drug release and kinet-
ics of drug release. The addition of the thermosensitive hydrogel-
forming polymer P407 to the formulations improved CHD release
from the tablets without negatively impacting on the duration of
mucoadhesion. In vivowork will be undertaken in the future to fur-
ther investigate the safety and efficacy of the prepared buccal
tablets for future application in the treatment of OPC.
Appendix A. Supplementary material
Supplementary data to this article can be found online at
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